AlphaQuest LLC Sells 35,428 Shares of Maximus, Inc. (NYSE:MMS)

AlphaQuest LLC decreased its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 94.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,060 shares of the health services provider's stock after selling 35,428 shares during the period. AlphaQuest LLC's holdings in Maximus were worth $154,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MMS. UMB Bank n.a. raised its position in Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after acquiring an additional 158 shares during the period. Eastern Bank bought a new position in Maximus in the fourth quarter worth approximately $29,000. V Square Quantitative Management LLC increased its stake in shares of Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after purchasing an additional 180 shares in the last quarter. R Squared Ltd purchased a new stake in shares of Maximus in the fourth quarter worth $54,000. Finally, IFP Advisors Inc increased its stake in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after purchasing an additional 302 shares in the last quarter. Institutional investors own 97.21% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on MMS. StockNews.com cut shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a research note on Thursday, January 2nd.

Remove Ads

Maximus Price Performance

MMS traded down $0.09 during trading on Friday, hitting $67.12. 1,927,282 shares of the company traded hands, compared to its average volume of 489,207. The company has a market cap of $3.80 billion, a PE ratio of 14.43 and a beta of 0.71. The stock's 50-day simple moving average is $71.27 and its two-hundred day simple moving average is $78.81. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82.

Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, sell-side analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.79%. Maximus's dividend payout ratio (DPR) is currently 25.81%.

Insider Buying and Selling at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the sale, the insider now owns 2,512 shares of the company's stock, valued at $171,167.68. This trade represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.